These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30279510)

  • 1. The mapping of cancer incidence and mortality trends in the UK from 1980-2013 reveals a potential for overdiagnosis.
    Oke JL; O'Sullivan JW; Perera R; Nicholson BD
    Sci Rep; 2018 Oct; 8(1):14663. PubMed ID: 30279510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global trends in thyroid cancer incidence and the impact of overdiagnosis.
    Li M; Dal Maso L; Vaccarella S
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):468-470. PubMed ID: 32445733
    [No Abstract]   [Full Text] [Related]  

  • 3. At-a-glance - Cancer trends in Canada, 1984 to 2015.
    Demers AA; Brenner DR; Smith L; Shaw A
    Health Promot Chronic Dis Prev Can; 2019 Nov; 39(11):310-314. PubMed ID: 31729314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less overdiagnosis of kidney cancer? an age-period-cohort analysis of incidence trends in 16 populations worldwide.
    Znaor A; Laversanne M; Bray F
    Int J Cancer; 2017 Sep; 141(5):925-932. PubMed ID: 28543047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The overdiagnosis of thyroid cancer should not be overinterpreted].
    Wu Y
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1561-1565. PubMed ID: 38742341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
    Vaccarella S; Franceschi S; Bray F; Wild CP; Plummer M; Dal Maso L
    N Engl J Med; 2016 Aug; 375(7):614-7. PubMed ID: 27532827
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic Scrutiny and Patterns of Elevated Cancer Risk: Uncovering Overdiagnosis Through Standardized Incidence Ratios.
    Chen Y; Gutierrez V; Morris L; Marti JL
    Cureus; 2023 Jul; 15(7):e42439. PubMed ID: 37637595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer trends in the UK.
    Bray F
    BMJ; 2024 Mar; 384():q504. PubMed ID: 38479756
    [No Abstract]   [Full Text] [Related]  

  • 9. Avoidable mortality in the UK unlikely to change soon.
    The Lancet Oncology
    Lancet Oncol; 2023 Sep; 24(9):945. PubMed ID: 37657464
    [No Abstract]   [Full Text] [Related]  

  • 10. Causation of increased prostate cancer in young men.
    Bleyer A; Spreafico F; Barr R
    Oncoscience; 2021; 8():37-39. PubMed ID: 33884284
    [No Abstract]   [Full Text] [Related]  

  • 11. Unpacking factors contributing to melanoma overdiagnosis: does polygenic risk play a role?
    Smit AK; Cust AE
    Br J Dermatol; 2023 Dec; 190(1):4-5. PubMed ID: 37942844
    [No Abstract]   [Full Text] [Related]  

  • 12. Overdiagnosis of Melanoma: Is It a Real Problem?
    Navarrete-Dechent C; Lallas A
    Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992356
    [No Abstract]   [Full Text] [Related]  

  • 13. Ecological evidence for melanoma overdiagnosis in Denmark.
    Olsen CM
    Br J Dermatol; 2024 May; ():. PubMed ID: 38752346
    [No Abstract]   [Full Text] [Related]  

  • 14. Variation in harms and benefits of prostate-specific antigen screening for prostate cancer by socio-clinical risk factors: A rapid review.
    Tesfai A; Norori N; Harding TA; Wong YH; Hobbs MD
    BJUI Compass; 2024 May; 5(5):417-432. PubMed ID: 38751945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
    Shelton J; Zotow E; Smith L; Johnson SA; Thomson CS; Ahmad A; Murdock L; Nagarwalla D; Forman D
    BMJ; 2024 Mar; 384():e076962. PubMed ID: 38479774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer agreement among specialists in the diagnosis of oral potentially malignant disorders and oral cancer using store-and-forward technology.
    Keerthi G; Mukhia N; Sunny SP; Song B; Raghavan SA; Gurudath S; Mendonca P; Li S; Patrick S; Imchen T; Leivon ST; Shruti T; Kolur T; Shetty V; Vidya Bhushan R; Ramesh RM; Pillai V; Kathryn OS; Smith PW; Suresh A; Liang R; Praveen Birur N; Kuriakose MA
    Clin Oral Investig; 2023 Dec; 27(12):7575-7581. PubMed ID: 37870594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures.
    Oke JL; Brown SJ; Senger C; Welch HG
    Br J Cancer; 2023 Jul; 129(1):3-7. PubMed ID: 37330566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
    Liao W; Coupland CAC; Innes H; Jepsen P; Matthews PC; Campbell C; ; Barnes E; Hippisley-Cox J
    EClinicalMedicine; 2023 May; 59():101969. PubMed ID: 37200996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical "Overdiagnosis".
    Wauchope BA; Coventry BJ; Roder DM
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The justification of non-obstetric ultrasound referrals: A safe and effective practice.
    Smith S; Parker T; Parker P
    Ultrasound; 2022 Feb; 30(1):52-61. PubMed ID: 35173779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.